Browsing eNauka
Browsing by Author Andreas, A. P.
Showing results 1 to 1 of 1
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2008 | High doses of imatinib mesylate (800 mg/day) significantly improve rates of major and complete cytogenetic remissions (mcr, ccr) - results from the first planned interim analysis of a multicenter, randomised, 2-arm - phase III study comparing imatinib standard dose (400 mg/day) with imatinib high do | Andreas, A. P.; Bošković, Darinka; Lejniece, S. | Conference Paper | Mp. category will be shown later |